Acne Claims For Cosmetics Leave Blemish On UK Advertising Regs
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Advertising Standards Authority issued decisions Oct. 17 on complaints against three cosmetics brands and an online beauty retailer for statements the independent regulator reads as acne-treatment claims, or the “spots” equivalent, calling them medicinal claims for unlicensed products.
You may also be interested in...
Skin 2 Spirit Scrubs Acne Claims On FDA Warning; Moon Valley Psoriasis Claim Persists
FDA’s warning letter to Skin 2 Sprit prompts a quick fix of website claims for the company’s skin care products. FDA advises Moon Valley Natural Products to correct claims that quality its skin care products as misbranded drugs.
Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.